IRADIMED CORPORATION (IRMD) 8-K Summary

Filing Date: November 3, 2025

This Form 8-K reports the announcement of financial results for the fiscal quarter ended September 30, 2025, via an accompanying press release (Exhibit 99.1).

Critical Note: The body of this 8-K does not contain specific financial metrics or operational data. Investors must refer directly to Exhibit 99.1 for quantitative details regarding performance and condition.

• Registrant: IRADIMED CORPORATION
• Exchange: NASDAQ Global Market (Ticker: IRMD)
• Key Filing Item: Item 2.02 (Results